Need help choosing between two Rx Co offers

Choosing between these two offers boils down to your long-term goals and what you value most in your career trajectory. Here's a breakdown based on the most helpful WSO content:

Tier 2 (FTI/BRG on the West Coast):

• Reputation & Growth in Rx: Tier 2 firms like FTI and BRG are more established in the restructuring (Rx) space and are likely experiencing stronger growth within the Rx world. This could provide you with deeper expertise and credibility in the field, which is valuable if you want to specialize in Rx or leverage that expertise for future opportunities.
• Exit Opportunities: A stronger Rx focus might better position you for distressed-focused roles or even SMB ownership, as you'll gain more technical expertise in areas like 13-week cash flow (13WCF) modeling and creditor-side advisory.
• Networking & Brand: The Tier 2 brand could carry more weight in the Rx world, which might help with credibility and connections down the line.

Tier 4 (Huron/Ankura in NYC):

• Location & Flexibility: NYC is a major financial hub, and being there could open doors to broader networking opportunities. The remote work option is a nice perk, offering flexibility, but it shouldn't be the sole deciding factor.
• Broader Skillset: The exposure to non-Rx work (e.g., 3-statement modeling) could help you develop a more diverse skillset, which aligns with your interest in SMB ownership. However, there's a risk of diluting your Rx expertise if you spend significant time on non-Rx projects.
• Middle Market Focus: Working with middle-market clients might provide more relevant experience for your eventual goal of becoming an SMB operator/owner. You'll likely gain insights into the challenges and operations of smaller businesses, which could be directly applicable to your future plans.

Key Considerations:

1. Long-Term Goals: If your ultimate goal is SMB ownership, the middle-market exposure at the Tier 4 firm could be more relevant. However, if you want to build a strong foundation in Rx first, the Tier 2 firm might be the better choice.
2. Skillset Development: Tier 4 offers broader exposure, but Tier 2 provides deeper Rx expertise. Consider which skillset will be more valuable for your next steps.
3. Location: NYC offers unparalleled networking opportunities, but the West Coast Tier 2 firm might provide a better work-life balance and a stronger Rx brand.
4. Growth Potential: Tier 2 firms are likely growing faster in the Rx space, which could mean more opportunities for advancement and learning within the field.

Recommendation:

If you're leaning toward a career that heavily involves Rx expertise or distressed-focused roles, Tier 2 (FTI/BRG) is the stronger choice. However, if you're prioritizing middle-market exposure and a broader skillset for SMB ownership, Tier 4 (Huron/Ankura) might align better with your goals.

Ultimately, think about where you see yourself in 5-10 years and which firm aligns best with that vision. Good luck with your decision!

Sources: MBB Implementation or 2nd Tier Generalist?, Choosing RX over M&A -- anyone recommend this?, Why You Should Consider Restructuring – Common Misconceptions/Insight on RX Groups, https://www.wallstreetoasis.com/forum/consulting/tier-2-big-city-vs-tier-1-outskirts?customgpt=1, Offer decision advice